bg
I

Ikena Oncology (IKNA)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About Ikena Oncology (IKNA)

Ikena Oncology, Inc. is a targeted oncology company, which develops medicines for patient groups with specific unmet needs. The Company lead targeted oncology product candidate, IK-930, is an oral small molecule inhibitor of the transcriptional enhan... Read more

  • USD1.35
  • USD1.38
  • USD1.30
  • USD7.64
  • -1.10%
  • 9M
  • 369.06k
  • 219.23k
  • 54M
  • 1.02
  • -77.00%

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.